ACell, Inc. announced that Sally Maher, JD has joined the company's Board of Directors. Maher is currently Edwards Lifesciences' Vice President of Regulatory and Clinical Affairs, Critical Care. Prior to Edwards, she served as Senior Vice President, Compliance and Government Affairs, for Smith & Nephew Endoscopy. Maher will replace James Osborne on the ACell Board of Directors. Mr. Osborne will continue to advise ACell as a consultant on the current medical device reimbursement landscape. Maher has also held positions with Johnson & Johnson, Pfizer Hospital Products Groups, and the US Food and Drug Administration.